22，Anderson HV. Estrogen therapy, atherosclerosis, and clinical cardiovascular events.Circulation, 1996,94:1809-1811.
33，Grady D,Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and rolonglife in postmenopausal women. Ann Intern Med, 1992,117:1016-1037.
44，Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? From beside tobench. Circulation, 1995, 92,5-8.
55，Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement onthe concentrations and metabolism of plasma lipoproteins. N Engl J Med,1991,325:1196-1204.
66，Hofmann SL, Eaton DL, Brown MS, et al. Overexpression of human w-density-lipoproteinreceptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J ClinInvest, 1990,85: 1542-1547.
77，Sack MN, Rader DJ, Cannon RO 3rd. Oestrogen and inhibition of oxidation oflow-density-lipoproteins in postmenopausal women.Lancet, 1994, 343:269-270.
88，Wander RC, Du SH, Ketchum SO, et al. Effects of interaction of RRR-alpha-tocopherylacetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with andwithout hormone-replacement therapy. Am J Clin Nutr, 1996,63:184-193.
1010，Hashimoto M, Akishita M,Eto M, et al. Modulation of endothelium-dependentflow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation,1995,92:3431-3435.
